Back to shop
Purity ≥99.0% (HPLC) Form Lyophilized powder CAS 2023788-19-2 Storage -20°C, protect from light
4.9(96 reviews)In stock
Tirzepatide 60mg
Tirzepatide is a dual GIP and GLP-1 receptor agonist under active metabolic research. This 60mg high-capacity vial is supplied as a lyophilized powder, sealed under inert atmosphere, with a Certificate of Analysis. For laboratory research use only.
$449.00
1
Encrypted checkout256-bit SSL
Stripe paymentsPCI-DSS L1
Batch guaranteeCOA or refund
Research supportMon–Fri
COA verified
Cold-chain shipping
HPLC tested
For laboratory and research use only. Not for human or veterinary use, diagnostic, or therapeutic purposes.
Smart recommendations
Researchers also selected
New-14%
5.0(74)10mg
Retatrutide 10mg
Triple-agonist research compound, 10mg lyophilized.
Only 7 leftShips today
$299.00$349.00
5.0(58)20mg
Retatrutide 20mg
Triple-agonist research compound, 20mg lyophilized.
In stockShips today
$329.00
New-16%
4.9(187)10mg
Tirzepatide 10mg
Dual GIP/GLP-1 research compound, 10mg lyophilized vial.
In stockShips today
$269.00$319.00
4.9(214)10mg
Semaglutide 10mg
GLP-1 receptor agonist research compound, 10mg vial.
In stockShips today
$219.00